TG. Lack of S100A1 in mice confers a gender-dependent hypertensive phenotype and increased mortality after myocardial infarction. Am J Physiol Heart Circ Physiol 296: H1457-H1465, 2009. First published March 13, 2009 doi:10.1152/ajpheart.00088.2008.-S100A1 is a small Ca 2ϩ -binding protein expressed in the myocardium and blood vessels that is downregulated in the diseased heart and plays a role in the regulation of cardiac muscle Ca 2ϩ homeostasis and contractility. To understand its physiological role under basal conditions and after myocardial infarction (MI), we used a mouse strain with targeted deletion of the S100A1 gene [S100A1 knockout (KO) mice]. We compared 49 wild-type (WT) and 56 S100A1 KO mice (6 -8 wk old) over 28 days after MI with sham-operated controls. We also examined the effect of S100A1 deficiency on vascular function of isolated blood vessels. S100A1 KO mice demonstrated worse survival compared with WT mice (21% vs. 69%, respectively, P Ͻ 0.001). Hemodynamic evaluation revealed a higher mean arterial pressure (MAP) in shamoperated KO animals compared with WT animals (99 Ϯ 4 vs. 77 Ϯ 3 mmHg, respectively, P Ͻ 0.001) that persisted in both groups after MI (86 Ϯ 2 vs. 66 Ϯ 4 mmHg, respectively, P Ͻ 0.001). Shamoperated male S100A1 KO mice had higher MAP than female KO mice (122 Ϯ 5 vs. 93 Ϯ 3 mmHg, respectively P Ͻ 0.05) and reduced survival after MI (4% vs. 27%, respectively, P Ͻ 0.05). In isolated aortas and mesenteric arteries, ACh-evoked vasodilatation in KO mice was significantly reduced compared with WT mice (P Ͻ 0.05). Nitric oxide production was reduced in endothelial cells isolated from KO mice. Thus, absence of S100A1 results in acute functional impairment and high mortality after MI associated with a gender-specific hypertensive phenotype. S100A1 appears to play a role in the endotheliumdependent regulation of blood pressure. Ca 2ϩ -binding protein; vascular tone; heart failure; hypertrophy; knockout S100A1 belongs to a multigenic family (21 members) of small (9 -13 kDa), nonubiquitous proteins characterized by the presence of two Ca 2ϩ -binding sites of the EF hand type (7). Demonstrating cell-and tissue-specific expression, they are involved in the regulation of protein phosphorylation, Ca 2ϩ homeostasis, energy metabolism, transcription factors, and the inflammatory response (5, 6, 37, 47) . S100A1 is expressed abundantly in cardiac and skeletal muscle cells but also in the lung, kidney, brain, and smooth muscle cells (4, 8, 12, 13, 15, 46, 47) . Associated with the sarcoplasmic reticulum (SR), mitochondria, and contractile elements of cardiac tissue (13, 15), S100A1 targets numerous myocardial intracellular proteins, including phospholamban, sarco(endo)plasmic reticulum Ca 2ϩ -ATPase 2 (SERCA2), ryanodine receptor 2 (RyR2), and the sarcomeric protein titin (16, 17, 24 -26, 28, 44). S100A1 plays a significant role in the regulation of cardiac Ca 2ϩ homeostasis and contractility (23, 25, 26, 28, 36) .
Ca
2ϩ -binding protein; vascular tone; heart failure; hypertrophy; knockout S100A1 belongs to a multigenic family (21 members) of small (9 -13 kDa), nonubiquitous proteins characterized by the presence of two Ca 2ϩ -binding sites of the EF hand type (7) . Demonstrating cell-and tissue-specific expression, they are involved in the regulation of protein phosphorylation, Ca 2ϩ homeostasis, energy metabolism, transcription factors, and the inflammatory response (5, 6, 37, 47) . S100A1 is expressed abundantly in cardiac and skeletal muscle cells but also in the lung, kidney, brain, and smooth muscle cells (4, 8, 12, 13, 15, 46, 47) . Associated with the sarcoplasmic reticulum (SR), mitochondria, and contractile elements of cardiac tissue (13, 15) , S100A1 targets numerous myocardial intracellular proteins, including phospholamban, sarco(endo)plasmic reticulum Ca 2ϩ -ATPase 2 (SERCA2), ryanodine receptor 2 (RyR2), and the sarcomeric protein titin (16, 17, 24 -26, 28, 44) . S100A1 plays a significant role in the regulation of cardiac Ca 2ϩ homeostasis and contractility (23, 25, 26, 28, 36) .
In isolated adult ventricular cardiomyocytes and engineered heart tissue, adenovirus-mediated overexpression of S100A1 has been found to enhance Ca 2ϩ transients, SR Ca 2ϩ uptake, and contractile performance (23) . In vitro beneficial effects on contractility have largely been attributed to its effects on the SR, specifically on both RyR2 and SERCA2a (16, 26, 28, 36, 42) , although myofibril function has also been shown to be regulated by S100A1 (44) .
The in vivo importance of S100A1 was first highlighted by reports showing that S100A1 is downregulated in heart failure (26, 29, 33, 35, 40) but upregulated in the right ventricle (RV) in response to pulmonary hypertension (9) . Interestingly, S100A1-deficient mice have normal cardiac function at rest but show dramatically reduced contractile reserve to acute and chronic hemodynamic stress and after cardiac injury (8, 29) . In contrast, cardiac-restricted overexpression of S100A1 in the mouse has been shown to lead to increased myocardial contractile performance and to preserve global cardiac function after acute myocardial infarction (MI) (28, 29) .
Although S100A1 has been shown to be expressed in vascular smooth muscle cells (VSMCs) (4, 19, 22) , less is known about its physiological function in this tissue. Interestingly, recent studies (19, 32) have demonstrated that S100A1 is also found in vascular endothelial cells (ECs) and that its level of expression is increased in ECs and smooth muscle cells of basilar rat arteries during artery vasospasms and regulates nitric oxide (NO) production. Using a S100A1-deficient mouse model, the present study examined the effect of S100A1 on basal hemodynamic and cardiac reserve after MI. We confirmed the importance of cardiac S100A1 in the maintenance of myocardial contractility after MI and that the absence of S100A1 in the vasculature is associated with a hypertensive phenotype that may contribute to adverse post-MI outcomes in this animal model. Furthermore, we propose that the contribution of S100A1 in the regulation of blood pressure is gender specific and involves endothelium-dependent mechanisms. MI. Mice were anesthetized using a mixture of 100 mg/kg ketamine (Bimeda-MTC Animal Health, Cambridge, ON, Canada) and 20 mg/kg xylazine (Bayer Canada, Etobicoke, ON, Canada) via an intraperitoneal injection. Endotracheal intubation was performed in the supine position under direct laryngoscopy using a blunt-ended small intravenous catheter, and mice were ventilated with a pressurecontrolled ventilator (Harvard Apparatus Canada, Saint-Laurent, QC, Canada; inspiratory pressure: 20 cmH 2O and respiratory rate: 120 breaths/min). Proper intubation was confirmed by observation of chest expansion and retraction during ventilated breaths. During the operation, animals were kept warm on a heating pad, and the pedal reflex was used as an indicator of anesthetia depth. The chest was opened by a horizontal incision through the skin and muscle layers, the pericardial sac was removed, and ischemia was achieved by ligating left anterior descending coronary artery (LAD) with a 7-0 silk suture at the mid-left ventricular (LV) level. Regional ischemia was confirmed by visual inspection of the occluded distal myocardium. A 6-0 silk suture was used to close the chest. Animals were removed from the ventilator, the endotracheal tube was withdrawn, and mice were given the analgesic buprenorphine hydrochloride (0.1 mg/kg) and kept warm until they had fully recovered from anesthesia. The procedure for sham-operated mice was the same with the exception that the LAD was not ligated.
Morphological assessment and MI sizing. After hemodynamic measurements, mice were killed by cervical dislocation, the heart and lungs were removed and briefly rinsed in a saline solution, and the atriums and RVs were dissected and weighted separately along with LVs. The LV was divided into two parts by a cross-sectional cut perpendicular to the long axis apical to the insertion of papillary muscles; the base of the heart was rapidly frozen in liquid nitrogen for subsequent protein analysis, and the apex was fixed in 10% formalin phosphate buffer for 3-4days. After fixation, the tissue was dehydrated and embedded in paraffin, and 5-m sections were obtained. Paraffin sections were stained with hematoxylin-eosin. A digital picture of the section was acquired using a Nikon Eclipse E800 (Nikon, Mississauga, ON, Canada) at ϫ10 magnification. The acquired image was then processed for computerized planimetry using an image-analysis program (ImageJ, National Institutes of Health). The size of the MI was expressed as the average percentage of scar endocardial and epicardial circumference.
Hemodynamic measurements. Mice were anesthetized with an intraperitoneal injection of a mixture of ketamine (100 mg/kg) and xylazine (20 mg/kg) 28 days after MI. Mice were then weighed and placed in the supine position on a heating pad to maintain adequate body temperature. Systemic systolic and diastolic arterial pressures were measured using a Millar micro-tipped catheter transducer (model SPR-671, Millar Instruments, Houston, TX) inserted into the right carotid artery. The catheter was then advanced into the LV for the measurement of LV pressures and the maximum rate of pressure rise (ϩdP/dtmax) and decline (ϪdP/dtmax). Pressure signals were recorded using a PowerLab data-acquisition system and analyzed via Chart 5 software (ADInstruments, Colorado Springs, CO). In a separate set of experiments, 10-to 12-wk-old male WT and S100A1 KO mice underwent baseline hemodynamic assessment by cardiac catheterization (as described above) under 2% isoflurane (Ohmeda Isotec4 vaporizer, Benson Medical Industries, Markham, ON, Canada). Isoflurane anesthesia was induced in a sealed chamber with 3-4% isoflurane and was maintained using a nose cone connected to the vaporizer.
In conscious mice, systolic blood pressure (SBP) was measured noninvasively by tail-cuff plethysmography (XBP1000, Kent Scientific, Torrington, CT) according to instructions supplied by the manufacturer.
Echocardiography. Transthoracic echocardiography was performed in mice anesthetized with 2% isoflurane. Isoflurane anesthesia was induced in a sealed chamber and was maintained using a nose cone connected to the vaporizer. Chest hair was removed with an electric razor and a topical depilatory agent. Two-dimensional echocardiography (Hewlett-Packard Sonos 5500, Philips Ultrasound, Bothel, WA) was performed using a broadband 5-to 12-MHz ultrasound probe (S12 transducer). Animals were imaged in the supine position. A standoff was created by using a small water bath. The imaging depth was set at 2 cm and magnified to 1 cm, allowing a frame rate of 100 -120 Hz. A short-axis two-dimensional view of the LV at the midpapillary muscle level was digitally acquired and stored on a magnetooptical drive for off-line analysis. End diastole was defined as the frame with the largest cavity size, and end systole was defined as the frame with the smallest cavity size. LV internal diameters at end diastole (LVIDd) and end systole (LVIDs) were measured on the two-dimensional image using the standard leading edge to leading edge technique. Each measure was made by a single observer blinded to the identity of the mice. For each measurement, three consecutive cardiac cycles were measured and then averaged. Fractional shortening (FS; in %) was calculated as (LVIDd Ϫ LVIDs)/LVIDd ϫ 100, and ejection fraction (EF) was calculated as (LVIDd 3 Ϫ LVIDs 3 )/ LVIDd 3 ϫ 100.
Measurement of isolated blood vessel isometric tension.
Mice not subjected to MI (10 -12 wk old) were killed by cervical dislocation, and 2-mm segments of the thoracic aorta and first-order mesenteric arterioles were mounted in a wire myograph (Living Systems) for measurements of isometric tension. Vessel segments were equilibrated in aerated Krebs-Henseleit solution [containing (in mmol/l) 120 NaCl, 25 NaHCO 3, 11.1 glucose, 4.76 KCl, 1.18 MgSO4, 1.18 KH 2PO4, and 2.5 CaCl2] for 1 h at 37°C under resting tensions of 1,000 and 200 mg for aortas and mesenteric arterioles, respectively. Cumulative concentrations of phenylephrine (10 nmol/l-100 mol/l) were added to the myograph chambers, and the resulting data were used to generate concentration-response curves. In a separate series of experiments, thoracic aortas and first-order mesenteric arterioles were first preconstricted with a submaximal concentration (EC75) of phenylephrine (1 mol/l for aortic segments and 30 mol/l for mesenteric arterioles), and relaxation responses to ACh (10 nmol/l-10 mol/l) were then calculated as a percentage of the phenylephrine-induced maximal response.
Isolation of ECs and Western blot analysis. ECs were isolated from the pulmonary vasculature of WT and KO animals and purified with the use of rat anti-mouse vascular-endothelial (VE-)cadherin antibody (BD Pharmigen)-coated magnetic beads, as previously described (10) . Cells were repurified with VE-cadherin antibody-coated magnetic beads during the first two passages, and cells from the third passage were used for experiments; 90 -95% of the cells were positive for EC markers: acetylated low-density lipoprotein (LDL; Molecular Probes, Invitrogen) or CD31 (R&D Systems). ECs were plated in 35-mm cell culture dishes and harvested at 80% confluency, and proteins were isolated. In addition, cardiac S100A1 expression levels were assessed in WT and KO mice of both genders. Protein samples were subjected to SDS-PAGE and subsequently transferred to nitrocellulose membranes. Membranes were probed with rabbit anti-human S100-␣ (1:1,000, GeneTex, San Antonio, TX) followed by an anti-rabbit IgG secondary antibody conjugated to horseradish peroxidase (HRP; 1:3,000, Promega, Madison, WI). Membranes were then stripped and reprobed using mouse monoclonal anti-␤-actin (1:8,000, Sigma) or anti-␣-actin (1:5,000, Chemicon, Temecula, CA) antibodies for normalization followed by anti-mouse HRP-conjugated IgG secondary antibody (1:3,000, Promega). In addition, rat anti-mouse EC-specific adhesion molecule VE-cadherin (1:1,000, BD Biosciences) was used followed by anti-mouse or anti-rat HRP-conjugated IgG secondary antibody (1:3,000, Promega).
Nitric oxide production in ECs. Nitric oxide (NO) production in 24-h conditioned media from ECs isolated from male and female mice was indirectly assessed using the Nitrate/Nitrite Fluorometric Assay Kit (Cayman Chemical, Ann Arbor, MI) according to the manufacturer's instructions.
Statistical analysis. All data are expressed as means Ϯ SE. Echocardiographic and hemodynamic data within groups were analysed by one-way ANOVA followed by Bonferroni's post hoc analysis, and between-group analyses were done by two-way ANOVA. Differences among multiple means were assessed using repeated-measures ANOVA where appropriate, and when overall differences were detected, individual means were compared by Bonferroni's post hoc analysis. When appropriate, differences between groups were assessed by using an unpaired Student's t-test (two tailed). Survival was plotted by Kaplan-Meier analysis, and comparison between groups was preformed using the log-rank test. Statistical analyses were carried out using Prism 4 (GraphPad Software, San Diego, CA). For all tests, a value of P Ͻ 0.05 was accepted as statistically significant.
RESULTS

S100A1 KO mice display decreased survival after MI.
We first examined the consequence of S100A1 deficiency on mortality after the induction of small to moderate MI (15-35% of the LV area), as previous studies have shown the importance of S100A1 in the adaptation to acute and chronic hemodynamic stress in vivo. Immunoblot analysis demonstrated high S100A1 cardiac expression in WT mice, an absence in KO mice, and no gender-based differences in S100A1 protein levels (Fig. 1A ). An identical pattern of S100A1 protein expression was also seen in isolated ECs in culture (Fig. 1B) .
A total of 56 WT and 49 S100A1 KO mice underwent LAD ligation. At 28 days after MI, surviving S100A1 KO animals had smaller infarct sizes compared with WT animals (P Ͻ 0.05; Table 1 ). Despite the difference in MI size in survivors, the overall 28-day post-MI survival was significantly lower in infarcted KO mice compared with WT mice (P Ͻ 0.0001; Fig.  2A ). In both groups, most of the deaths occurred in the first 24 h after MI; the remaining deaths took place in the first week, with only one death occurring in the WT group beyond 1 wk. There were five deaths in the sham-operated KO group (exclusively males) but no deaths in the sham-operated WT group.
To determine the cause of death in KO mice, coronary ligation was performed in three anesthetized KO mice during acute hemodynamic recording with a micromanometer placed in the LV. All KO mice died of rapid progressive hemodynamic collapse unrelated to cardiac arrhythmias (data not shown). Postmortem pathological examination in KO animals revealed no evidence of cardiac rupture.
Morphological measurements. Table 1 shows the morphological parameters. There were no differences in body weights among the four groups. With MI, WT and S100A1 KO mice developed increased heart weights and heart-to-body weight ratios compared with sham-operated mice (P Ͻ 0.01).
Hemodynamic and echocardiographic measurements. Hemodynamic and echocardiographic data are also shown in Table 1 . In vivo hemodynamic assessment by cardiac catheterization revealed a higher mean arterial pressure (MAP) in S100A1 KO mice compared with WT (P Ͻ 0.001). This difference in MAP between KO and WT mice was associated with no significant differences in heart rate (HR), LV end-diastolic pressure, ϩdP/dt max , or ϪdP/dt max . Moreover, S100A1 KO and WT mice exhibited similar echocardiographic characteristics.
The induction of MI decreased MAP to similar degree (ϳ14%) in WT and S100A1 KO groups, with persistently higher MAP in the post-MI KO group. Surviving animals at 28 days after MI had increased LVIDs and decreased FS and EF in both S100A1 KO and WT groups (P Ͻ 0.001).
Male S100A1 KO mice displayed higher systemic pressure and decreased survival compared with females. Relative to female S100A1 KO mice, male S100A1 KO mice demonstrated significantly lower survival rates over the 28-day observation period (P Ͻ 0.05; Fig. 2B ). This gender-specific difference in survival led us to compare hemodynamic parameters in male and female KO mice. Unexpectedly, of the 26 male KO mice that underwent coronary ligation, only one male KO mouse survived the 28-day followup period. Consequently, only hemodynamic data from sham-operated animals could be analyzed. These data are shown in Table 2 . There were no Fig. 1 . S100A1 protein content in the myocardium (A) and endothelial cells (ECs; B) from male and female wild-type (WT) and knockout (KO) mice. Representative Western blots demonstrated no differences in S100A1 protein levels between male and female in both the heart and ECs, as confirmed by densitometry analysis normalized to ␣-actin and ␤-actin, respectively (n ϭ 6). Expression of vascular-endothelial (VE-)cadherin confirmed the endothelial phenotype of ECs (B). differences between male and female WT in any of the parameters analyzed. In contrast, MAP was significantly higher in male KO mice compared with female KO mice (P Ͻ 0.001). This difference in blood pressure was not accompanied by any changes in ϩdP/dt max , ϪdP/dt max , or HR.
The anesthetic xylazine acts as a hypertensive agent in male S100A1 KO mice. To determine if the difference in MAP between sham-operated WT and KO animals was affected by the anesthetia used, experiments using nonoperated male animals were carried out using isoflurane (2%) instead of the mixture of ketamine-xylazine (Table 3) . Interestingly, the hypertensive phenotype, although attenuated, persisted in S100A1 KO mice. Importantly, the hypertension observed in male KO mice was sufficient to induce cardiac hypertrophy, as reflected by significantly increased heart/body weight ratios compared with age-matched 10-to 12-wk-old male WT mice (P Ͻ 0.05).
Subsequent hemodynamic assessments by LV catheterization revealed that ketamine alone was not differentially modulating the blood pressure in WT and KO mice (data not shown). Xylazine at a dose of 20 mg/kg induced a characteristic decrease in blood pressure, ϩdP/dt max , and HR (Fig. 3 , A-C) in male WT but, in striking contrast, caused a paradoxical increase in blood pressure in male KO mice starting at 3 min after the xylazine injection (P Ͻ 0.001; Fig. 3A) . Whereas ϩdP/dt max decreased in both groups, it decreased to a lesser degree in S100A1 KO compared with WT mice (P Ͻ 0.01; Fig. 3B ).
Hemodynamic assessment in conscious mice by tail-cuff plethysmography further confirmed the hypertensive phenotype observed in S100A1 KO mice. Male KO mice exhibited higher SBP compared with female KO mice (137 Ϯ 4 vs. 123 Ϯ 5 mmHg, respectively, P Ͻ 0.05, n ϭ 4 -5). WT mice had significantly lower SBP than KO mice (WT mice: 112 Ϯ 3 mmHg, P Ͻ 0.05, n ϭ 7), and there were no gender differences in SBP in WT mice.
Absence of S100A1 in the endothelium is associated with decreased ACh-induced vasorelaxation. As the expression of S100A1 in ECs isolated from WT mice and its absence in KO mice was confirmed by Western blot analysis in both genders (Fig. 1B) , vascular function in isolated vessels was examined.
Superfusion of ACh (10 nmol/l-10 mol/l) induced endothelium-dependent relaxation in isolated mesenteric and aortic segments in a concentration-dependent manner. In male WT mice, maximum vasorelaxation in mesenteric and aortic segments was 97.0 Ϯ 0.6% and 68.7 Ϯ 4.4% of the phenylephrine-induced constriction (Fig. 4, A and B, respectively) . In S100A1 KO mice, maximum relaxation was significantly reduced in both vessel preparations (74.3 Ϯ 8.6% and 54.7 Ϯ 3.9%). In addition, maximum relaxation in mesenteric segments from female KO mice was significantly decreased compared with female WT mice (78.1 Ϯ 8.7% vs. 97.9 Ϯ 2.8%, respectively; Fig. 4A ) with only modest differences from KO males with a trend to greater relaxation to ACh in KO females at submaximal doses of 10 Ϫ7 M and 10 Ϫ6.5 M. Confirming a role for NO production in these responses, treatment of mesenteric vessels with the NO synthase inhibitor N G -nitro-Larginine methyl ester (L-NAME; 300 M) greatly reduced the maximum relaxation induced by ACh and abolished differences between KO and WT mice (n ϭ 8 -9, 23.6 Ϯ 7.6% vs. 31.5 Ϯ 7.4%, respectively).
EC 50 logarithmic values were unchanged in isolated mesenteric and aortic segments from male animals (Ϫ7.182 Ϯ 0.164 vs. Ϫ7.335 Ϯ 0.076 and Ϫ6.423 Ϯ 0.390 vs. Ϫ6.739 Ϯ 0.121; Fig. 4 , A and B, respectively) and mesenteric segments from KO and WT female mice (Ϫ7.277 Ϯ 0.112 vs. Ϫ7.219 Ϯ 0.107; Fig. 4A, respectively) . In a separate series of experiments, concentration-response curves to phenylephrine were constructed to determine the EC 75 values used to preconstrict vessels for subsequent ACh vasorelaxation experiments. Vasoconstriction evoked by increasing concentrations of phenylephrine was similar in both KO and WT groups (Fig. 5, A and B; EC 50 log: mesentery arteries, Ϫ6.118 Ϯ 0.12 vs. Ϫ6.005 Ϯ 0.129; and aortas, Ϫ6.470 Ϯ 0.098 vs. Ϫ6.664 Ϯ 0.091, respectively), indicating that the observed differences in AChinduced vasorelaxation were not a result of variations in baseline contraction between groups.
To further confirm the link between S100A1 and NO production, we quantified nitrate/nitrite (NO 3 /NO 2 ) in KO and WT pulmonary vascular EC-conditioned media. NO production in ECs was significantly lower in KO compared with WT animals (Fig. 6) . Moreover, ECs isolated from male KO mice showed significantly reduced NO production compared with female KO mice, but no gender-specific differences were observed in WT mice. Fig. 2 . Post-myocardial infarction (MI) survival rates of WT and S100A1 KO mice (A) and male and female S100A1 KO mice (B). A: 28-day post-MI survival was significantly reduced in S100A1 KO mice compared with WT mice (69% vs. 21%, respectively, P Ͻ 0.0001). B: gender-specific comparison in S100A1 KO mice revealed higher survival rates in female animals compared with male animals (27% vs. 4%, respectively, P Ͻ 0.05).
DISCUSSION
In this report, we demonstrate that 1) S100A1 deficiency in mice results in acute functional impairment and high early mortality after MI, 2) the highest mortality was observed in male KO mice in association with gender-related higher basal and postinfarct systemic blood pressure; and 3) isolated vessels from KO mice exhibited impaired endothelium-dependent relaxation compared with WT mice. This study corroborates findings from other laboratories that demonstrated the importance of myocardial S100A1 for the adaptation to acute and chronic hemodynamic stress (8, 26, 27, 29, 33) . It also extends recent observations demonstrating that S100A1 expression in the endothelium regulates vascular function in vivo and in vitro by describing a clear gender-specific difference in endothelium-dependent vascular responses in S100A1 KO mice (32) . S100A1 deficiency is associated with decreased survival after MI. S100A1 KO mice had a very poor early survival rate, specifically in the first hours after MI, which was related to hemodynamic collapse and not to arrhythmia or cardiac rupture. This is in line with previous observations of reduced survival 28 days after large MI survival in S100A1 KO mice compared with control mice (29) . S100A1 deficiency in mice is associated with a defective contractile reserve and poor adaptative response to increased hemodynamic stress (8) . In contrast, transgenic mice with cardiac-specific overexpression of S100A1 exhibited enhanced in vivo cardiac function at base- Values are means Ϯ SE; n, no. of mice. WT, wild type; KO, knockout; MI, myocardial infarction; LV, left ventricle; SBP, systolic blood pressure; DBP, diastolic blood pressure; MAP, mean arterial pressure; LVSP, LV systolic pressure; LVEDP, LV end-diastolic pressure; ϩdP/dtmax, maximal rate of pressure rise; ϪdP/dtmax, maximal rate of pressure decline; HR, heart rate. Animals were 10 -12 wk old at the time of death. *P Ͻ 0.05 between MI and sham-operated groups; †P Ͻ 0.05 vs. the respective WT groups. Values are means Ϯ SE; n, no. of mice. *P Ͻ 0.05 vs. S100A1 KO female mice; †P Ͻ 0.0001 vs. WT mice. Values are means Ϯ SE; n, no. of mice. Animals were 10 -12 wk old at the time of death. *P Ͻ 0.05 vs. WT mice.
line and in response to ␤-adrenergic stimulation (28) as well as preserved global contractility and better survival (82% vs. 57%) after MI compared with controls (29) . Taken together, the cumulative data support an important role for S100A1 in maintaining adequate cardiac reserve in response to an acute or chronic increase in hemodynamic demand. S100A1 has been shown to interact with and regulate the activity of RyR2 and SERCA2a in cardiac myocytes (16, 28, 36, 42) . Both proteins are considered to play essential roles in increasing the Ca 2ϩ transient amplitude after increased hemodynamic demand and ␤-adrenergic activation (21) . A decrease in SERCA2 and RyR2 functions could then have accounted, at least in part, for the decreased inotropic reserve and mortality observed in KO mice.
Despite similar structural and functional alterations, KO mice who survived 28 days had smaller infarct size compared with WT mice. While we cannot exclude that S100A1 could modulate infarct size directly, this has not been supported in a previous study (29) of KO animals subjected to large MI. It is more likely that the smaller infarct size in KO animals reflects a survival bias; that is, the small number of KO animals surviving to day 28 were more likely to have experienced smaller infarction. Furthermore, that KO animals exhibit comparable functional impact and structural remodeling as WT animals despite significantly smaller infarcts supports that S100A1 is required for the maintenance of cardiac performance after MI. Indeed, previous studies (29, 40) have demonstrated an increase in apoptosis in KO mice after MI and a cardioprotective effect of S100A1 on isolated myocytes that would be counterintuitive to our observations in the absence of a survivor bias. The very low survival rate in S100A1 male KO mice precluded additional histopathological assessment in this study.
S100A1 KO mice demonstrate a gender-dependent elevation in systemic blood pressure. S100A1 KO mice of either sex had higher baseline systemic blood pressure compared with WT mice with persistent elevation after MI. This hypertensive phenotype was not associated with alterations in measures of cardiac contractility, filling pressures, or HR, in keeping with an increase in peripheral vascular resistance secondary to an impact of S100A1 on vascular responses. We postulate that the hypertensive phenotype may, in addition to the impact of absence of S100A1 on myocardial contractility and reserve, contribute to increased mortality after infarction.
Our findings are in contrast with previous reports (8, 29 ) that found similar baseline hemodynamic parameters between S100A1 KO and WT mice. In part, these differences could result from the use of different anesthesia regimens, given that the blood pressure varied importantly according to the anesthetics used in our study. The largest difference in blood pressure between WT and S100A1 KO animals occurred with the anesthesia combination of ketamine and xylazine (Table 2) . Intriguingly, we demonstrated a paradoxical increase in blood pressure in KO animals in response to xylazine. Xylazine is a clonidine analog that, at low doses, acts mainly centrally through the stimulation of ␣ 2 -adrenoceptors (␣ 2 -ARs) to produce, apart from its analgesic and sedative effects, hypotension and bradycardia. It also decreases norepinephrine release from postganglionic adrenergic neurones by stimulating presynaptic ␣ 2 -ARs to cause vasodilatation, but also acts peripherally to cause vasoconstriction by stimulating postsynaptic ␣ 2 -ARs located on VSMCs (14, 18) . Our data show that S100A1 KO mice have greater peripheral vasoconstrictive responses than WT mice to xylazine injection, which could possibly be attributed to an increased response of VSMCs to the agonist and/or a reduced endothelium-dependent vasodilatation, given that ␣ 2 -ARs are also functionally expressed on the vascular endothelium and produce vasorelaxation upon activation (2, 30, 39 ). Previous studies (31, 45) have suggested that endothelial ␣ 2 -ARs may be involved in the antihypertensive action of clonidine (31, 45) . On the other hand, we believe that central autonomic dysregulation could not have explain the effects of xylazine in our KO mice given that components of the central effect were not different between the two groups, as seen by Fig. 4 . Concentration-dependent relaxation to ACh of male and female mesenteric arterioles (A) and male thoracic aortas (B) from WT and S100A1 KO mice. Vessel segments were precontracted with a submaximal concentration of phenylephrine (EC75). ACh-induced vasorelaxation is expressed as a percentage of the phenylephrine-induced maximal response. *P Ͻ 0.05, male KO mice compared with male WT mice; **P Ͻ 0.05 female KO mice compared with female WT mice. similar decreases in early blood pressure and HR responses (Fig. 3, A and C) . This also argues against a generalized increase in sympathetic tone in KO animals. Although KO animals did not exhibit any basal difference in ␤-adrenergic density in cardiac muscle (8) , we cannot exclude a less likely specific increase in sympathetic traffic to the vasculature that would not be addressed by global measurements such as plasma catecholamine levels.
Absence of S100A1 is associated with a defect in endothelium-dependent vasorelaxation. While S100A1 is found both in the endothelium and VSMCs (4, 19, 22) , its physiological function in blood vessels and contribution to the regulation of blood pressure have not been fully elucidated. We confirmed the expression of S100A1 in the endothelium and provide functional data in vessels isolated from KO and WT animals. Using cell culture techniques, we also present mechanistic data demonstrating a crucial link between S100A1 protein expression and NO production.
The vasodilatation induced by the endothelium-dependent vasodilator ACh was reduced in both conduit and resistance arteries isolated from S100A1 KO compared with WT mice. We cannot fully exclude that hypertension itself in vivo contributes to endothelial dysfunction, but the recent observation that the use of small interfering RNA to S100A1 in ECs in culture resulted in reduced NO generation suggests, at least in part, a direct effect (32) . Previous studies (1, 3, 11, 43) have shown that the ACh-induced vasorelaxation is primarily mediated by NO in large vessels such as the aorta, whereas in resistance vessels, other mediators (such as prostacyclin and endothelium-derived hyperpolarizing factor) contribute to the vasodilatatory response. As inhibition of NO production with L-NAME eliminated the differences between WT and KO vessels, we confirmed that the vascular endothelial dysfunction found in S100A1 KO mice can be primarily attributed to an abnormality in NO signaling (32) . While NO-dependent relaxation may be reduced by increased production of ROS (not examined in this report), the observation that S100A1-depleted ECs exhibited reduced NO production/bioavailability (Fig. 6) supports a relationship between S100A1 and NO synthase activity. While a decrease in endothelial intracellular Ca 2ϩ concentration has been shown to explain, at least in part, the reduced NO production observed in S100A1 KO ECs (32) , additional experiments will be required to determine by which mechanism(s) gender influences this response.
Whether this altered vascular responsiveness is the consequence of both a reduction in NO production/bioavailability and a reduced response of VSMCs to NO (20) is amenable to further experimental testing. The ability of S100A1 KO animals to respond fully to phenylephrine-provoked vasoconstriction supports comparable myogenic responses, but assessment of baseline myogenic tone with perfusion myography is required to exclude any contribution of basal differences in myogenic tone.
Gender differences in the regulation of blood pressure have been extensively documented in humans and various animal models over the past years (for reviews, see Refs. 34 and 41). The lack of specific differences between the response of isolated vessels from S100A1 KO male and female mice, despite differences observed in endothelial NO production, suggest that in vivo factors extrinsic to the vessels themselves may contribute in part to the impact of abrogating S100A1 on blood pressure. While NO has been shown to play an important role in the beneficial effect of estrogens on endotheliumdependent vasodilatation, interestingly, a recent study (18) found that the disruption of the endothelial NO synthase gene in mice did not significantly affect blood pressure in females but render males markedly hypertensive compared with C57/ BL6 control mice. Future studies in female KO mice subjected to oophorectomy may contribute to our understanding of such mechanisms, but our data support that the NO pathway is involved and plays a role in the gender-specific hypertensive phenotype in S100A1 KO mice.
In summary, S100A1 depletion in mice was associated with elevated systemic blood pressure, reduced endothelium-dependent vasorelaxation, and decreased survival after MI. Recognizing the previously identified direct impact of S100A1 on the maintenance of myocardial contractility, we postulate that hypertension associated with the absence of S100A1 also contributes to the impairment of cardiac functional reserve and increased mortality after MI. Thus, S100A1 may be an important regulator of integrated cardiac and vascular regulation of hemodynamics in health and disease. As such, it may offer a promising therapeutic target for common cardiovascular conditions, including hypertension, MI, and heart failure.
